IP Library Patent Application 14579670
Patent Application
App. No. 14/579,670

System for Clinical Trial Subject Compliance

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/579,670
Abstract

The present invention is designed to develop research protocols for clinical trials. The invention also can track and enhance subject compliance with a research protocol. The invention further provides evaluability data related to subject performance in the clinical trial. According to an alternative embodiment of the invention, a portable electronic device is used to query and collect data from the subject.

Claims (81)

1 .- 53 . (canceled)

54 . A method of increasing subject compliance during a clinical trial by improving oversight, the method comprising:

receiving, over a network from a first portable electronic device, first data associated with a first subject of the clinical trial, the first data comprising:

first clinical trial data provided by the first subject; and

first evaluability data associated with first clinical trial data, the first evaluability data indicating the suitability of the first clinical trial data for use in the clinical trial;

receiving, over the network from the first portable electronic device, second data associated with the first subject, the second data comprising:

second clinical trial data provided by the first subject after the provision of the first clinical trial data; and

second evaluability data associated with the second clinical trial data, the second evaluability data indicating the suitability of the second clinical trial data for use in the clinical trial;

generating, by a computer processor, a report providing a graphical display of the first and second evaluability data;

communicating the report over the network to one or more of the following recipients:

a researcher conducting the clinical trial; and

a sponsor of the clinical trial.

55 . The method of claim 54 , further comprising receiving, over the network from a second portable electronic device, third data associated with a second subject of the clinical trial, the third data comprising:

third clinical trial data provided by the second subject; and

third evaluability data associated with third clinical trial data, the third evaluability data indicating the suitability of the third clinical trial data for use in the clinical trial;

wherein the report further provides a graphical display of the third evaluability data.

56 . The method of claim 54 , further comprising storing the first data in a database associated with a server comprising the computer processor.

57 . The method of claim 54 , wherein the first evaluability data comprises data indicating timeliness of the first clinical trial data.

58 . The method of claim 54 , wherein the first clinical trial data comprises one or more of the following data:

a response to a question presented to the first subject via a portable electronic device;

a report associated with administration of a medication to the first subject;

a report associated with pain reduction;

a report associated with a bowel movement;

a report associated with an asthmatic episode; and

a cognitive measurement.

59 . The method of claim 54 , wherein the first clinical trial data comprises data received by the portable electronic device from a physiological measurement device.

60 . The method of claim 54 , further comprising administering a reward to the first subject based at least on the first evaluability data.

61 . A non-transient computer-readable medium comprising instructions operable, when executed by one or more computer processors of a computer system, to cause the computer system to:

receive, over a network from a first portable electronic device, first data associated with a first subject of the clinical trial, the first data comprising:

first clinical trial data provided by the first subject; and

first evaluability data associated with first clinical trial data, the first evaluability data indicating the suitability of the first clinical trial data for use in the clinical trial;

receive, over the network from the first portable electronic device, second data associated with the first subject, the second data comprising:

second clinical trial data provided by the first subject after the provision of the first clinical trial data; and

second evaluability data associated with the second clinical trial data, the second evaluability data indicating the suitability of the second clinical trial data for use in the clinical trial;

generate a report providing a graphical display of the first and second evaluability data;

communicate the report over the network to one or more of the following recipients:

a researcher conducting the clinical trial; and

a sponsor of the clinical trial.

62 . The medium of claim 61 , wherein the instructions are further operable to cause the computer system to receive, over the network from a second portable electronic device, third data associated with a second subject of the clinical trial, the third data comprising:

third clinical trial data provided by the second subject; and

third evaluability data associated with third clinical trial data, the third evaluability data indicating the suitability of the third clinical trial data for use in the clinical trial;

wherein the report further provides a graphical display of the third evaluability data.

63 . The medium of claim 61 , wherein the instructions are further operable to cause the computer system to store the first data in a database associated with a server comprising the one or more computer processors.

64 . The medium of claim 61 , wherein the first evaluability data comprises data indicating timeliness of the first clinical trial data.

65 . The medium of claim 61 , wherein the first clinical trial data comprises one or more of the following data:

a response to a question presented to the first subject via a portable electronic device;

a report associated with administration of a medication to the first subject;

a report associated with pain reduction;

a report associated with a bowel movement;

a report associated with an asthmatic episode; and

a cognitive measurement.

66 . The medium of claim 61 , wherein the first clinical trial data comprises data received by the portable electronic device from a physiological measurement device.

67 . The medium of claim 61 , wherein the instructions are further operable to cause the computer system to administer a reward to the first subject based at least on the first evaluability data.

68 . A system for reporting data related to a clinical trial, the system comprising:

one or more computer processors; and

a non-transient computer-readable medium comprising instructions operable, when executed by the one or more computer processors, to cause the system to:

receive, over a network from a first portable electronic device, first data associated with a first subject of the clinical trial, the first data comprising:

first clinical trial data provided by the first subject; and

first evaluability data associated with first clinical trial data, the first evaluability data indicating the suitability of the first clinical trial data for use in the clinical trial;

receive, over the network from the first portable electronic device, second data associated with the first subject, the second data comprising:

second clinical trial data provided by the first subject after the provision of the first clinical trial data; and

second evaluability data associated with the second clinical trial data, the second evaluability data indicating the suitability of the second clinical trial data for use in the clinical trial;

generate a report providing a graphical display of the first and second evaluability data;

communicate the report over the network to one or more of the following recipients:

a researcher conducting the clinical trial; and

a sponsor of the clinical trial.

69 . The system of claim 68 , wherein the instructions are further operable to cause the system to receive, over the network from a second portable electronic device, third data associated with a second subject of the clinical trial, the third data comprising:

third clinical trial data provided by the second subject; and

third evaluability data associated with third clinical trial data, the third evaluability data indicating the suitability of the third clinical trial data for use in the clinical trial;

wherein the report further provides a graphical display of the third evaluability data.

70 . The system of claim 68 , wherein the instructions are further operable to cause the system to store the first data in a database associated with a server comprising the one or more computer processors.

71 . The system of claim 68 , wherein the first evaluability data comprises data indicating timeliness of the first clinical trial data.

72 . The system of claim 68 , wherein the first clinical trial data comprises one or more of the following data:

a response to a question presented to the first subject via a portable electronic device;

a report associated with administration of a medication to the first subject;

a report associated with pain reduction;

a report associated with a bowel movement;

a report associated with an asthmatic episode; and

a cognitive measurement.

73 . The system of claim 68 , wherein the first clinical trial data comprises data received by the portable electronic device from a physiological measurement device.

74 . The system of claim 68 , wherein the instructions are further operable to cause the system to administer a reward to the first subject based at least on the first evaluability data.

Assignments (9)
RELEASE OF SECURITY INTEREST AT REEL/FRAME 051832/0777 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ERESEARCHTECHNOLOGY, INC.; BIOMEDICAL SYSTEMS LLC (F/K/A BIOMEDICAL SYSTEMS CORPORATION)
Reel/Frame 069939/0212 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME 051837/0001 Recorded Jan 17, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ERESEARCHTECHNOLOGY, INC.; BIOMEDICAL SYSTEMS LLC (F/K/A BIOMEDICAL SYSTEMS CORPORATION)
Reel/Frame 069939/0303 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2020
From: NEWSTAR FINANCIAL, INC.
To: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
Reel/Frame 051754/0838 →
SECOND LIEN SECURITY AGREEMENT Recorded Feb 6, 2020
From: BIOMEDICAL SYSTEMS LLC; ICARDIAC TECHNOLOGIES LLC; ERESEARCHTECHNOLOGY, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 051837/0001 →
FIRST LIEN SECURITY AGREEMENT Recorded Feb 5, 2020
From: BIOMEDICAL SYSTEMS LLC; ICARDIAC TECHNOLOGIES LLC; ERESEARCHTECHNOLOGY, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 051832/0777 →
RELEASE OF SECURITY INTEREST Recorded Feb 4, 2020
From: GOLDMAN SACHS BANK USA
To: ERESEARCH TECHNOLOGY, INC.; BIOMEDICAL SYSTEMS CORPORATION; ICARDIAC TECHNOLOGIES, INC.
Reel/Frame 051717/0031 →
SECURITY INTEREST Recorded Jun 6, 2016
From: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
To: NEWSTAR FINANCIAL, INC., AS COLLATERAL AGENT
Reel/Frame 038812/0804 →
SECURITY AGREEMENT Recorded May 2, 2016
From: ERESEARCHTECHNOLOGY, INC.; PHT CORPORATION
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 038591/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2015
From: HUFFORD, MICHAEL; PETERSON, DAVID; PATY, JEAN; SHIFFMAN, SAUL
To: ERESEARCH TECHNOLOGY, INC.
Reel/Frame 036457/0954 →